As the most frequently mutated member of TET family, TET2 is often mutated in both lymphoid malignancies (such as T cell lymphoma 30%–40%) and myeloid malignancies, especially acute myeloid leukemia (AML, 7%–23%) [11, 12]. This evidence concerns the gene TET2 and acute myeloid leukemia.